PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Bariatric Fellow, Phoenix Health, Chester CH1 6LT, United Kingdom.\', \'President British Obesity and Metabolic Surgery Society, Visiting Professor University of Chester, CEO Phoenix Health, United Kingdom. Electronic address: david.kerrigan@phoenix-health.co.uk.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0306-9877(20)31148-810.1016/j.mehy.2020.109883
?:doi
?:hasPublicationType
?:journal
  • Medical hypotheses
is ?:pmid of
?:pmid
?:pmid
  • 32492562
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.443
?:rankingScore_hIndex
  • 75
is ?:relation_isRelatedTo_publication of
?:title
  • The association between obesity and poor outcome after COVID-19 indicates a potential therapeutic role for montelukast.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all